Down‐regulated miR‐625 suppresses invasion and metastasis of gastric cancer by targeting ILK
Ming Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Bingya Liu(Shanghai Jiao Tong University), Xin Lv(Tongji University), Ying Qu(Chinese Academy of Sciences), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Jingfang Ju(Stony Brook University), Yingyan Yu(Fujian Medical University), Min Yan(Zhengzhou University), Jianfang Li(Shanghai Jiao Tong University), Hui Nie(Central South University), Liping Su(Guangdong Provincial People's Hospital), Chenglong Li(Wuhan University), Xuehua Chen(Nanjing University of Chinese Medicine), Qinlong Gu(Shanghai Jiao Tong University), Beiqin Yu(Ruijin Hospital)
Cited by 67
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
Exosomes derived from miR‐181‐5p‐modified adipose‐derived mesenchymal stem cells prevent liver fibrosis <i>via</i> autophagy activation
|Journal of Cellular and Molecular Medicine|2017|389
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298
CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
|Journal of Experimental & Clinical Cancer Research|2019|231